XML 76 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
OPERATING ACTIVITIES      
Net income (loss) $ 932 $ 584 $ (1,311)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Provision (credit) for loan and lease losses (60) 638 3,159
Depreciation and amortization expense 270 330 389
FDIC (payments) net of FDIC expense 46 105 (466)
Deferred income taxes (benefit) (310) 80 (878)
Net losses (gains) and writedown on OREO 9 60 86
Expense (income) on trading credit default swaps 41 23 37
Provision (credit) for losses on LIHTC guaranteed funds (5) 8 17
Provision (credit) for customer derivative losses (21) 4 40
Net losses (gains) from loan sales (75) (76) 1
Net losses (gains) from principal investing (78) (66) 4
Provision (credit) for losses on lending-related commitments (28) (48) 67
Losses (gains) on leased equipment (25) (20) (99)
Net securities losses (gains) (1) [1] (14) [1] (113) [1]
Gain from sale/redemption of Visa Inc. shares     (105)
Gain related to exchange of common shares for capital securities     (78)
Gain from sale of Key's claim associated with the Lehman Brothers' bankruptcy     (32)
Intangible asset impairment     241
Net decrease (increase) in loans held for sale excluding loan transfers from continuing operations (163) 383 295
Net decrease (increase) in trading account assets 362 224 71
Other operating activities, net 996 509 995
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 1,890 2,724 2,320
INVESTING ACTIVITIES      
Proceeds from sale/redemption of Visa Inc. shares     105
Net decrease (increase) in short-term investments (2,175) 399 3,478
Purchases of securities available for sale (624) (9,914) (15,501)
Proceeds from sales of securities available for sale 1,667 142 2,970
Proceeds from prepayments and maturities of securities available for sale 5,000 4,685 4,275
Purchases of held-to-maturity securities (2,175) (2) (6)
Proceeds from prepayments and maturities of held-to-maturity securities 83 6 7
Purchases of other investments (138) (190) (177)
Proceeds from sales of other investments 90 216 41
Proceeds from prepayments and maturities of other investments 111 133 70
Net decrease (increase) in loans, excluding acquisitions, sales and transfers (303) 5,850 11,066
Proceeds from loan sales 143 620 380
Purchases of premises and equipment (158) (156) (229)
Proceeds from sales of premises and equipment 1 3 16
Proceeds from sales of other real estate owned 120 182 114
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 1,642 1,974 6,609
FINANCING ACTIVITIES      
Net increase (decrease) in deposits 1,346 (4,961) 444
Net increase (decrease) in short-term borrowings (1,148) 1,114 (7,952)
Net proceeds from issuance of long-term debt 1,031 797 763
Payments on long-term debt (2,215) (1,657) (3,726)
Net proceeds from issuance of common shares and preferred stock 604   986
Series B Preferred Stock - TARP redemption (2,500)    
Repurchase of common stock warrant (70)    
Tax benefits over (under) recognized compensation cost for stock-based awards     (5)
Cash dividends paid (164) (184) (213)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (3,116) (4,891) (9,703)
NET INCREASE (DECREASE) IN CASH AND DUE FROM BANKS 416 (193) (774)
CASH AND DUE FROM BANKS AT BEGINNING OF YEAR 278 471 1,245
CASH AND DUE FROM BANKS AT END OF YEAR 694 278 471
Additional disclosures relative to cash flows:      
Interest paid 605 879 1,489
Income taxes paid (refunded) (305) (164) (121)
Noncash items:      
Loans transferred to portfolio from held for sale     199
Loans transferred to held for sale from portfolio 98 407 311
Loans transferred to other real estate owned $ 49 $ 210 $ 264
[1] Key did not have impairment losses related to securities recognized in earnings in 2011 and 2010. Impairment losses and the portion of those losses recorded in equity as a component of AOCI on the balance sheet totaled $11 million and $3 million, respectively, for 2009.